Empagliflozin can be used to lower the potential risk of cardiovascular Loss of life in individuals with type 2 diabetes and coronary heart or blood vessel disorder.In clinical scientific studies, Jardiance and Invokana ended up both successful at treating type 2 diabetes and lowering sure coronary heart-associated hazards. Even so, these two drugs